US President George W. Bush announced plans to appoint Eric Lander to the National Cancer Advisory Board last week. Lander, director of the Whitehead Institute/MIT Center for Genome Research, would serve on the board, which oversees the National Cancer Institute and provides peer review for NCI grant applications, for the remainder of a six-year term that expires in March 2006.
A number of comings and goings at Lion Bioscience: Klaus Tschira, a SAP co-founder who joined Lion’s supervisory board in 1998, has stepped down from the board to devote more time to his private foundation, the Klaus Tschira Foundation, which he founded in 1995 to support cutting-edge IT R&D projects. Lion plans to appoint Richard Roy, the former head of Microsoft Germany, as Tschira’s successor. In addition, following the discontinuation of Lion’s drug discovery business, CSO Jan Mous has left the company. He will continue to act as a consultant for Lion. Finally, Lion tapped Reiner Doelle for the newly created position of vice president for global software development. Doelle, a former IBM sales and marketing executive, will report directly to Lion CEO Friedrich von Bohlen. He will be responsible for strengthening the company’s international project management and software development productivity.